Rubius Therapeutics Inc (NASDAQ:RUBY)

16.26
Delayed Data
As of Oct 22
 -0.02 / -0.12%
Today’s Change
4.20
Today|||52-Week Range
38.71
+114.23%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Rubius Therapeutics Inc have a median target of 30.50, with a high estimate of 40.00 and a low estimate of 20.00. The median estimate represents a +87.58% increase from the last price of 16.26.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Rubius Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.56
Sales
$0.00
Reporting Date
Nov 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.60%
 
 
 
 
 
 
Growthannually -6.25%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.